The present invention relates to an inclusion complex of Rifampicin and cyclodextrin (CD) that can be used as an anti-tubercular drug. The present invention also relates to a process for synthesizing inclusion complexes of the anti-tubercular drug, Rifampicin, with -CD (-cyclodextrin) and HP--CD (2-hydroxy propyl cyclodextrin) and characterization of these inclusion complexes.